SEC Comment Letter for NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Apr 6, 2018

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: April 6, 2018 · CIK: 0001072379 · Accession: 0000000000-18-010429

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-35737

Date

April 5, 2018

Author

Linda Powers

Form

UPLOAD

Company

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)

Letter

April 5, 2018 Linda Powers Chief Executive Officer and Chairman Northwest Biotherapeutics, Inc. 4800 Montgomery Lane, Suite 800 Bethesda, MD 20814 Re:Northwest Biotherapeutics, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 26, 2018 File No. 001-35737 Dear Ms. Powers: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Division of Corporation Finance Office of Healthcare & Insurance cc: Eric Scarazzo

Show Raw Text

April 5, 2018
Linda Powers
Chief Executive Officer and Chairman
Northwest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800
Bethesda, MD 20814
Re:Northwest Biotherapeutics, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed March 26, 2018
File No. 001-35737
Dear Ms. Powers:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Eric Scarazzo

SecProbe.io